Keywords: astellas/neurosearch, initiate, ph, ib, trial, acr16, danish

Astellas/NeuroSearch initiate Ph Ib trial of ACR16

Article | 16 April 2007

Print This

Danish drugmaker NeuroSearch's development and license partner Astellas Pharma has enrolled and dosed the first patients in a clinical Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in